- Selecting first-line bevacizumab-containing therapy for advanced brea…
Number of the records: 1  

Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses

  1. Authority Brodowicz, T. (Bibliographic antecedent)
    TitleSelecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses / Brodowicz, T. - Špánik, S. ... [et al.]
    Another responsib. Špánik, Stanislav, 1959- (Bibliographic antecedent)
    Redakcia Onkológia (Adapter)
    Translated titleVýber prvolíniovej liečby obsahujúcej bevacizumab pre pokročilý karcinóm prsníka: Turandot analýza rizikových faktorov
    NoteBr J Cancer. 2014 Sep 30. [Epub ahead of print]
    In Onkológia. -- ISSN 1336-8176. -- Roč. 9, č. 6 (2014), s. 404-405
    Call numberC 3069
    MeSH Subject nádory prsníka - farmakoterapia
    metastázy nádorové
    protokoly kombinovanej protinádorovej chemoterapie
    receptor erbB-2
    skúšanie randomizované kontrolované ako téma
    Keywords bevacizumab
    Form, Genre abstrakt v angličtine
    LanguageEnglish
    CountrySlovakia
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.